Related Experiment Video

Updated: Mar 3, 2026

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia
07:18

Cell-based Assay to Study Antibody-mediated Tau Clearance by Microglia

Published on: November 9, 2018

9.0K

Microglia-Synapse Pathways: Promising Therapeutic Strategy for Alzheimer's Disease

Jingdun Xie1, Haitao Wang2, Ting Lin3

  • 1Department of Anesthesiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Guangzhou 510060, China.

Biomed Research International
|May 6, 2017
PubMed

Insights

Microglia-mediated neuroinflammation and microglia-synapse pathways are key factors in Alzheimer's disease (AD) pathogenesis. This review discusses their roles and mechanisms in AD, highlighting the need for further research into these critical pathways.

Area of Science:

  • Neuroscience
  • Immunology
  • Pathology

Background:

  • Alzheimer's disease (AD) is characterized by amyloid plaques and tau tangles.
  • The precise mechanisms driving AD neuropathology are not fully understood.
  • Microglia-driven neuroinflammation is increasingly recognized as a significant contributor to AD.

Purpose of the Study:

  • To review the evidence linking microglia and synapse dysfunction in AD.
  • To elucidate the role of microglia in AD pathogenesis.
  • To discuss the mechanisms of microglia-synapse pathways in AD.

Main Methods:

  • Literature review of microglia studies in AD.
  • Analysis of research on synapse dysfunction in AD.
  • Synthesis of evidence on microglia-synapse interactions in AD pathogenesis.

Main Results:

  • Microglia play a crucial role in the neuroinflammatory processes underlying AD.
  • Synapse dysfunction is a key feature of AD pathology.
  • Microglia-synapse pathways are central to the progression of AD.

Conclusions:

  • Microglia-mediated neuroinflammation is a critical factor in AD.
  • Understanding microglia-synapse pathways is essential for developing AD therapies.
  • Further research is needed to fully elucidate these complex mechanisms.

More Related Videos

Author Spotlight: In Vitro Co-Culture Model for Studying Microglia-Neuronal Interactions in Disease Conditions08:47

Author Spotlight: In Vitro Co-Culture Model for Studying Microglia-Neuronal Interactions in Disease Conditions

Published on: July 26, 2024

3.9K
Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates09:12

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

16.8K

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.9K